Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

ClinicalTrials.gov ID: NCT00977080

Public ClinicalTrials.gov record NCT00977080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH With Paricalcitol-centered Therapy vs. Cinacalcet Therapy With Low-dose Vitamin D in Hemodialysis Patients With Secondary Hyperparathyroidism

Study identification

NCT ID
NCT00977080
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Abbott
Industry
Enrollment
272 participants

Conditions and interventions

Interventions

  • Paricalcitol Drug
  • Cinacalcet Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Apr 30, 2011
Completion
Apr 30, 2011
Last update posted
Jun 19, 2012

2009 – 2011

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Site Reference ID/Investigator# 22781 Tempe Arizona 85284
Site Reference ID/Investigator# 24342 Chula Vista California 91910
Site Reference ID/Investigator# 21142 Los Angeles California 90033
Site Reference ID/Investigator# 22762 Los Angeles California 90048
Site Reference ID/Investigator# 22758 Riverside California 92505
Site Reference ID/Investigator# 21442 San Diego California 92123
Site Reference ID/Investigator# 23688 Arvada Colorado 80002
Site Reference ID/Investigator# 21370 Coral Springs Florida 33071
Site Reference ID/Investigator# 25902 Hudson Florida 34667
Site Reference ID/Investigator# 21146 Lauderdale Lakes Florida 33313
Site Reference ID/Investigator# 26743 Lauderdale Lakes Florida 33313
Site Reference ID/Investigator# 22788 Miami Florida 33173
Site Reference ID/Investigator# 22722 Orlando Florida 32806
Site Reference ID/Investigator# 23147 Tampa Florida 33614
Site Reference ID/Investigator# 22778 Meridian Idaho 83642
Site Reference ID/Investigator# 21369 Detroit Michigan 48202
Site Reference ID/Investigator# 22786 Detroit Michigan 48236
Site Reference ID/Investigator# 21144 St Louis Missouri 63110
Site Reference ID/Investigator# 21443 St Louis Missouri 63110
Site Reference ID/Investigator# 21145 Omaha Nebraska 68131
Site Reference ID/Investigator# 22505 Flushing New York 11355
Site Reference ID/Investigator# 22759 Toledo Ohio 43606
Site Reference ID/Investigator# 22796 Lancaster Pennsylvania 17604
Site Reference ID/Investigator# 22770 Philadelphia Pennsylvania 19106
Site Reference ID/Investigator# 22772 Aiken South Carolina 29801
Site Reference ID/Investigator# 21147 Orangeburg South Carolina 29115
Site Reference ID/Investigator# 22982 Houston Texas 77030
Site Reference ID/Investigator# 21143 Houston Texas 77099
Site Reference ID/Investigator# 22506 San Antonio Texas 78215
Site Reference ID/Investigator# 22776 Bluefield West Virginia 24701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00977080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00977080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →